IL17A and autoimmune disease: The fact that A20 restricts IL-17 signaling and the concomitant decrease of its own implicates a negative feedback loop that maintains an equilibrium between inflammatory responses and homeostasis, avoiding excessive tissue damage and autoimmune disorders.